Item 1.01. Entry into a Material Definitive Agreement
As previously disclosed, at a special meeting of the stockholders of Bannix Acquisition Corp. held on March 8, 2023,. | May 12, 2023
Item 8.01 Other Events.
Supplement to the Definitive Proxy Statement
On April 24, 2023, Prime Number Acquisition I Corp. filed a
definitive proxy statement (as supplemented on May 2, 2023 and. | May 10, 2023
Item 8.01. Other Events.
As previously disclosed, Sorrento Therapeutics, Inc. was engaged in arbitration before the American Arbitration
Association against NantPharma, LLC . | April 20, 2023
Item 8.01. Other Events.
As previously disclosed, Sorrento Therapeutics, Inc. was engaged in arbitration before the American Arbitration
Association against NantPharma, LLC . | April 10, 2023
Item 7.01 Regulation FD Disclosure
On April 4, 2023, the Company issued a press release announcing final set of
drill results from the 2022 field program at the Arctic Project. The press
release is. | April 4, 2023